table of content
1 Study Coverage
1.1 Tardive Dyskinesia (TD) Treatment Drugs Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million) Introduction
1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size for the Year 2017-2028
1.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size for the Year 2017-2028
1.3 Tardive Dyskinesia (TD) Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Tardive Dyskinesia (TD) Treatment Drugs in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Tardive Dyskinesia (TD) Treatment Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Tardive Dyskinesia (TD) Treatment Drugs Market Dynamics
1.4.1 Tardive Dyskinesia (TD) Treatment Drugs Industry Trends
1.4.2 Tardive Dyskinesia (TD) Treatment Drugs Market Drivers
1.4.3 Tardive Dyskinesia (TD) Treatment Drugs Market Challenges
1.4.4 Tardive Dyskinesia (TD) Treatment Drugs Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Tardive Dyskinesia (TD) Treatment Drugs by Type
2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Segment by Type
2.1.1 Valbenazine
2.1.2 Deutetrabenazine
2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2028)
2.4 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017, 2022 & 2028)
2.5 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size by Type (2017-2028)
3 Tardive Dyskinesia (TD) Treatment Drugs by Application
3.1 Tardive Dyskinesia (TD) Treatment Drugs Market Segment by Application
3.1.1 Hospitals
3.1.2 Clinic
3.1.3 Others
3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2028)
3.4 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017, 2022 & 2028)
3.5 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size by Application (2017-2028)
4 Global Tardive Dyskinesia (TD) Treatment Drugs Competitor Landscape by Company
4.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Company
4.1.1 Top Global Tardive Dyskinesia (TD) Treatment Drugs Companies Ranked by Revenue (2021)
4.1.2 Global Tardive Dyskinesia (TD) Treatment Drugs Revenue by Player (2017-2022)
4.2 Global Tardive Dyskinesia (TD) Treatment Drugs Concentration Ratio (CR)
4.2.1 Tardive Dyskinesia (TD) Treatment Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Tardive Dyskinesia (TD) Treatment Drugs in 2021
4.2.3 Global Tardive Dyskinesia (TD) Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Tardive Dyskinesia (TD) Treatment Drugs Headquarters, Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.1 Global Tardive Dyskinesia (TD) Treatment Drugs Headquarters and Area Served
4.3.2 Global Tardive Dyskinesia (TD) Treatment Drugs Companies Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Tardive Dyskinesia (TD) Treatment Drugs Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Tardive Dyskinesia (TD) Treatment Drugs Market Size by Company
4.5.1 Top Tardive Dyskinesia (TD) Treatment Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Tardive Dyskinesia (TD) Treatment Drugs Revenue by Players (2020, 2021 & 2022)
5 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region
5.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2017-2028)
5.2.1 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region: 2017-2022
5.2.2 Global Tardive Dyskinesia (TD) Treatment Drugs Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Tardive Dyskinesia (TD) Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Tardive Dyskinesia (TD) Treatment Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Tardive Dyskinesia (TD) Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Tardive Dyskinesia (TD) Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Tardive Dyskinesia (TD) Treatment Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 Neurocrine Biosciences, Inc.
7.1.1 Neurocrine Biosciences, Inc. Company Details
7.1.2 Neurocrine Biosciences, Inc. Business Overview
7.1.3 Neurocrine Biosciences, Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.1.4 Neurocrine Biosciences, Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.1.5 Neurocrine Biosciences, Inc. Recent Development
7.2 Teva Pharmaceutical Industries
7.2.1 Teva Pharmaceutical Industries Company Details
7.2.2 Teva Pharmaceutical Industries Business Overview
7.2.3 Teva Pharmaceutical Industries Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.2.4 Teva Pharmaceutical Industries Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.2.5 Teva Pharmaceutical Industries Recent Development
7.3 Pfizer Inc.
7.3.1 Pfizer Inc. Company Details
7.3.2 Pfizer Inc. Business Overview
7.3.3 Pfizer Inc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.3.4 Pfizer Inc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.3.5 Pfizer Inc. Recent Development
7.4 Biogen
7.4.1 Biogen Company Details
7.4.2 Biogen Business Overview
7.4.3 Biogen Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.4.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.4.5 Biogen Recent Development
7.5 Novartis AG
7.5.1 Novartis AG Company Details
7.5.2 Novartis AG Business Overview
7.5.3 Novartis AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.5.4 Novartis AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.5.5 Novartis AG Recent Development
7.6 AstraZeneca
7.6.1 AstraZeneca Company Details
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.6.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.6.5 AstraZeneca Recent Development
7.7 GlaxoSmithKline plc.
7.7.1 GlaxoSmithKline plc. Company Details
7.7.2 GlaxoSmithKline plc. Business Overview
7.7.3 GlaxoSmithKline plc. Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.7.4 GlaxoSmithKline plc. Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.7.5 GlaxoSmithKline plc. Recent Development
7.8 Bayer AG
7.8.1 Bayer AG Company Details
7.8.2 Bayer AG Business Overview
7.8.3 Bayer AG Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.8.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.8.5 Bayer AG Recent Development
7.9 Sanofi
7.9.1 Sanofi Company Details
7.9.2 Sanofi Business Overview
7.9.3 Sanofi Tardive Dyskinesia (TD) Treatment Drugs Introduction
7.9.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Drugs Business (2017-2022)
7.9.5 Sanofi Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
